Literature DB >> 14637309

Global BOLD MRI changes to ventilatory challenges in congenital central hypoventilation syndrome.

Paul M Macey1, Jeffry R Alger, Rajesh Kumar, Katherine E Macey, Mary A Woo, Ronald M Harper.   

Abstract

We evaluated global blood oxygen level dependent (BOLD) signal changes in gray and white matter in 14 congenital central hypoventilation syndrome (CCHS) and 14 control subjects. One baseline image series with room air and three series with 30 s room air followed by 120 s hypercapnia (5% CO2/95% O2), hypoxia (15% O2/85% N2) or hyperoxia (100% O2) were collected. Hypercapnia and hyperoxia raised, and hypoxia lowered gray and white matter global signal in both groups, with smaller changes in white matter. Signal changes in CCHS cases were lower than control subjects for hypercapnia in gray and white matter, slightly more-enhanced in hypoxia, and, except for initial transient responses, were nearly comparable during hyperoxia. Initial signal rate or pattern changes emerged in all three challenges in gray or white matter in control, but not CCHS cases. Neural or vascular mechanisms mediate perfusion differently in CCHS; the aberrant initial transient responses may reflect deficiencies in rapidly-varying physiologic interactions in the syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637309     DOI: 10.1016/j.resp.2003.09.006

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  13 in total

1.  Central autonomic regulation in congenital central hypoventilation syndrome.

Authors:  J A Ogren; P M Macey; R Kumar; M A Woo; R M Harper
Journal:  Neuroscience       Date:  2010-03-06       Impact factor: 3.590

2.  Decreased cortical thickness in central hypoventilation syndrome.

Authors:  Paul M Macey; Ammar S Moiyadi; Rajesh Kumar; Mary A Woo; Ronald M Harper
Journal:  Cereb Cortex       Date:  2011-09-30       Impact factor: 5.357

3.  Images in sleep medicine. Altered cerebral blood flow in a patient with congenital central hypoventilation syndrome.

Authors:  Paul M Macey; Rajesh Kumar; Jennifer A Ogren; Mary A Woo; Ronald M Harper
Journal:  Sleep Med       Date:  2010-05-13       Impact factor: 3.492

4.  Magnetic resonance imaging of vascular oxygenation changes during hyperoxia and carbogen challenges in the human retina.

Authors:  Yi Zhang; Qi Peng; Jeffrey W Kiel; Carlos A Rosende; Timothy Q Duong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

Review 5.  Congenital central hypoventilation syndrome and the PHOX2B gene: a model of respiratory and autonomic dysregulation.

Authors:  Pallavi P Patwari; Michael S Carroll; Casey M Rand; Rajesh Kumar; Ronald Harper; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2010-06-30       Impact factor: 1.931

Review 6.  Affective brain areas and sleep-disordered breathing.

Authors:  Ronald M Harper; Rajesh Kumar; Paul M Macey; Mary A Woo; Jennifer A Ogren
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

7.  Dilated basilar arteries in patients with congenital central hypoventilation syndrome.

Authors:  Rajesh Kumar; Haidang D Nguyen; Paul M Macey; Mary A Woo; Ronald M Harper
Journal:  Neurosci Lett       Date:  2009-10-12       Impact factor: 3.046

8.  Resting-state white matter-cortical connectivity in non-human primate brain.

Authors:  Tung-Lin Wu; Feng Wang; Muwei Li; Kurt G Schilling; Yurui Gao; Adam W Anderson; Li Min Chen; Zhaohua Ding; John C Gore
Journal:  Neuroimage       Date:  2018-09-08       Impact factor: 6.556

9.  Hippocampal volume reduction in congenital central hypoventilation syndrome.

Authors:  Paul M Macey; Christopher A Richard; Rajesh Kumar; Mary A Woo; Jennifer A Ogren; Christina Avedissian; Paul M Thompson; Ronald M Harper
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

10.  Hyperoxic brain effects are normalized by addition of CO2.

Authors:  Paul M Macey; Mary A Woo; Ronald M Harper
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.